Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study.
Luchetti, Michele Maria; Benfaremo, Devis; Ciccia, Francesco; Bolognini, Laura; Ciferri, Monia; Farinelli, Alessia; Rossini, Matteo; Mosca, Piergiorgio; Triolo, Giovanni; Gabrielli, Armando.
World J Gastroenterol
; 23(39): 7139-7149, 2017 Oct 21.
Artigo em Inglês | MEDLINE | ID: mdl-29093622
Clinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis.
Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.
[Clinical value of Short Form-36 and clinical measures in a prospective cohort study of ankylosing spondylitis patients].
Effectiveness of ultrasound treatment applied with exercise therapy on patients with ankylosing spondylitis: a double-blind, randomized, placebo-controlled trial.
ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis.
Direct and indirect costs associated with ankylosing spondylitis and related disease activity scores in Turkey.
Quality of life is associated with physical activity and fitness in cystic fibrosis.
Relationship between psychiatric status, self-reported outcome measures, and clinical parameters in axial spondyloarthritis.
Quality of life as measured by the short-form 36 (SF-36) questionnaire in patients with early systemic sclerosis and undifferentiated connective tissue disease.
Defining functioning categories in axial Spondyloarthritis: the role of the ASAS Health Index.